Related Experiment Video
Updated: Aug 12, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Effects of short-term PAP treatment on endurance exercise performance in obstructive sleep apnea patients
D Edward Shifflett1, E W. Walker, J M. Gregg
1Laboratory for Health and; Exercise Sciences, 230 War Memorial Hall, Virginia Polytechnic Institute and State University, VA 24061, Blacksburg, USA
Abstract:
Objective: To measure the effects of 4 weeks of nasal positive airway pressure therapy (PAP) on exercise performance in obstructive sleep apnea patients (OSA).Background: Little published research is available which describes the effects of OSA on exercise tolerance or upon the potential of exercise testing to evaluate the outcomes of PAP therapy.Methods: Exercise testing was performed on an electronic cycle ergometer with continuous ramping to allow collection of numerous data points for each subject, up to a vigorous terminal intensity. Linear regression established each subject's pre-treatment scores for the dependent variables at 60% of estimated peak power (W(60%)). Responses at the pre-treatment W(60%) test were used to quantify and compare to responses at the same power output after treatment.Results: OSA by nocturnal polysomnography was moderately severe in this group; the respiratory distress index was 48+/-22 (mean+/-SD; n=9). Exercise heart rates after PAP therapy averaged 10.2 bt/min less at W(60%) (P<0.05). Other variables were lower but non-significantly so, further suggesting a lower cardiorespiratory exercise demand after treatment, i.e. oxygen consumption ( downward arrow7.6%), and Rating of Perceived Exertion ( downward arrow8.8%).Conclusion: Brief treatment with PAP therapy improves objective markers of aerobic exercise performance.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Sleep Apnea
The condition is more prevalent among...
Heart Failure VI: Adjunct Therapies

